A systematic review to evaluate the evidence base (in cluding clinical and cost-effectiveness) for EMDR in PTSD treatment and prevention to address the NICE guidance caveats for the use of EMDR in the treatment and prevention of PTSD in children, adolescents and adults

Description

EMDR Association UK believes that the NICE guidance for PTSD (NG116) is out of date and that new evidence would support the fact that EMDR may be an efficacious and cost-effective treatment for PTSD compared to alternatives. The Association therefore commissioned The Sheffield School of Health and Related Research (SCHARR) to evaluate the evidence base for EMDR in PTSD treatment and prevention in order to address the NICE guidance caveats for the use of EMDR in the treatment and prevention of PTSD in children, adolescents and adults and to provide a research summary that justifies advocating for EMDR as the primary recommended treatment for PTSD.

Format

Conference

Language

English

Author(s)

Anthea Sutton

Original Work Citation

Sutton, A. (2024, March). A systematic review to evaluate the evidence base (in cluding clinical and cost-effectiveness) for EMDR in PTSD treatment and prevention to address the NICE guidance caveats for the use of EMDR in the treatment and prevention of PTSD in children, adolescents and adults. Presentation at the EMDR UK Association 22nd Conference & AGM & Online, Glasgow, UK

Citation

“A systematic review to evaluate the evidence base (in cluding clinical and cost-effectiveness) for EMDR in PTSD treatment and prevention to address the NICE guidance caveats for the use of EMDR in the treatment and prevention of PTSD in children, adolescents and adults,” Francine Shapiro Library, accessed April 27, 2024, https://francineshapirolibrary.omeka.net/items/show/29044.

Output Formats